Using Sherlock and clinicaltrials.gov data to understand nocebo effects and adverse event dropout rates in the placebo arm

Journal of Pain

Volumn 14, Issue 9, 2013, Pages 999-

  Cepeda, M Soledad ^a   Lobanov, Victor ^a   Berlin, Jesse A ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADVERSE OUTCOME; CLINICAL TRIAL (TOPIC); DATA BASE; LETTER; NOCICEPTION; PAIN; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PLACEBO EFFECT; PLANNING; QUANTITATIVE ANALYSIS; STUDY DESIGN;

ANALGESICS; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN;

EID: 84883754601     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2013.06.005     Document Type: Letter

References (3)

1. M.S. Cepeda, J.A. Berlin, C.Y. Gao, F. Wiegand, and D.R. Wada Placebo response changes depending on the neuropathic pain syndrome: Results of a systematic review and meta-analysis Pain Med 13 2012 575 595
2. M.S. Cepeda, V. Lobanov, and J.A. Berlin From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results Clin Trials 10 2013 347 348
3. M.S. Cepeda, V. Lobanov, and J.A. Berlin Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials J Pain 14 2013 405 411